by Inari | Jul 8, 2019 | News
IRVINE, CALIFORNIA – July 2, 2019 — Inari Medical, Inc. announced today that the company has appointed Thomas M. Tu, M.D. as Chief Medical Officer. Dr. Tu is a pioneer in definitive catheter-based treatment of pulmonary embolism (PE). He was the lead author in...
by Inari | May 7, 2019 | News
IRVINE, CALIFORNIA – May 7, 2019 — Inari Medical, Inc. announced today the publication of its 106-patient prospective multicenter FlowTriever Mechanical Pulmonary Embolectomy (FLARE) study for the treatment of intermediate-risk pulmonary embolism (PE). The...
by Inari | Oct 1, 2018 | News
IRVINE, CALIFORNIA – September 27, 2018 — Inari Medical, Inc. announced today the enrollment of the first patient in the ClotTriever Outcomes Registry (“CLOUT”) using the ClotTriever® Thrombectomy System. CLOUT is a 500-patient prospective, multicenter,...
by Inari | May 21, 2018 | News
IRVINE, CALIFORNIA – May 21, 2018 – Inari Medical, Inc., announced today the FlowTriever System has received FDA 510(k) clearance for the treatment of pulmonary embolism (“PE”). This clearance makes the FlowTriever System the first and only thrombectomy device cleared...
by Inari | Apr 30, 2018 | News
Multicenter FLARE Study for PE Treatment IRVINE, CALIFORNIA – April 27, 2018 – Inari Medical, Inc., announced today the presentation of results from its FlowTriever Pulmonary Embolectomy (“FLARE”) Clinical Study that evaluated the safety and effectiveness of the...